Methods for Screening Therapeutic Agent for Protein Conformational Diseases
KR101581721B1
Compositions supportive for treating drug-resistanced breast cancer containing miR-500a-3p and sensitizing method for anticancer reagent in drug-resistanced breast cancer patient
KR101648783B1
Mobile electronic-display application
KR101660638B1
Composition for preventing or treating listeriosis comprising FXR inhibitor
KR20150136001A
A Composition for inhibiting Growth of Cancer Stem Cells, containing Erk signaling activation inhibitor
KR20160110773A
Method and apparatus for tracking moving object by using kalman filter
KR20160107477A
Compositions supportive for treating drug-resistanced breast cancer containing LY6K expression inhibitors or miR-192-5p inhibitors
KR20160093826A
Protein controlling plant growth or morphology, and mathod of controlling plant growth or morphology by using thereof
KR20160091594A
Device for extracting paste contents
KR101612934B1
System for mission meal and method for executing the mission meal using the same
KR101590953B1
A multi-function tea bag holder and a tea note
KR20160069425A
Use of Kazinol C for treating or preventing cancer
KR20160066724A
Functional food composition for improving gastrointestinal function comprising glucosamine
KR101620022B1
Pharmaceuical composition for the prevention and treatment of type 1 diabetes comprising Polyphenols extracted from Broussonetia kazinoki as an active ingredient
KR101618124B1
Pharmaceutical composition for treating autosomal dominant polycystic kidney disease containing intraflagellar transport 46 and autosomal dominant polycystic kidney disease animal model
KR20160049312A
Compostion for reducing side effect of anticancer drug
KR20160049216A
Composition comprising carnosic acid for preventing or improving menopausal symptoms
KR20160047332A
Marker for Retinal Development and Use thereof
KR20160020674A
A pharmaceutical composition containing 2-hydroxy-7-methyl octahydrophenanthrene derivative as an estrogen receptor ligand or a pharmaceutically acceptable salt thereof as an effective component
KR20150139231A
Compositions of markers for diagnosing hydrocephalus comprising Anks1a protein
